Baijin Life Science Holdings Limited

SEHK:1466 Stock Report

Market Cap: HK$472.9m

Baijin Life Science Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure3yrs

Recent management updates

Recent updates

Baijin Life Science Holdings Limited (HKG:1466) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Sep 01
Baijin Life Science Holdings Limited (HKG:1466) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Subdued Growth No Barrier To Baijin Life Science Holdings Limited (HKG:1466) With Shares Advancing 40%

Apr 03
Subdued Growth No Barrier To Baijin Life Science Holdings Limited (HKG:1466) With Shares Advancing 40%

Affluent Partners Holdings Limited's (HKG:1466) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jun 07
Affluent Partners Holdings Limited's (HKG:1466) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Affluent Partners Holdings (HKG:1466) Is Posting Healthy Earnings, But It Is Not All Good News

Dec 26
Affluent Partners Holdings (HKG:1466) Is Posting Healthy Earnings, But It Is Not All Good News

Affluent Partners Holdings (HKG:1466) Is Carrying A Fair Bit Of Debt

Feb 02
Affluent Partners Holdings (HKG:1466) Is Carrying A Fair Bit Of Debt

Affluent Partners Holdings (HKG:1466) Is Making Moderate Use Of Debt

Sep 02
Affluent Partners Holdings (HKG:1466) Is Making Moderate Use Of Debt

Does Affluent Partners Holdings (HKG:1466) Have A Healthy Balance Sheet?

Nov 28
Does Affluent Partners Holdings (HKG:1466) Have A Healthy Balance Sheet?

CEO

Baijin Life Science Holdings has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Sze Ming Cheung
CFO, Company Secretary & Executive Director7.6yrsHK$902.00kno data
Peng Dong
Executive Director2.1yrsHK$960.00kno data
Yaoyao Su
Executive Director1.7yrsHK$506.00kno data
2.1yrs
Average Tenure
42yo
Average Age

Experienced Management: 1466's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sze Ming Cheung
CFO, Company Secretary & Executive Director7.6yrsHK$902.00kno data
Peng Dong
Executive Director2.1yrsHK$960.00kno data
Yaoyao Su
Executive Director1.7yrsHK$506.00kno data
Yongjun Zhu
Non-Executive Director3.2yrsHK$240.00kno data
Siu Keung Wong
Independent Non-Executive Director3.8yrsHK$216.00kno data
Ka Leung Lee
Independent Non-Executive Director2yrsHK$216.00kno data
Chi Kin Cheng
Non-Executive Director6.2yrsHK$240.00kno data
Chunyu Chang
Independent Non-Executive Director3yrsHK$216.00kno data
Chunchen Xie
Non-Executive Directorless than a yearHK$66.00kno data
3.0yrs
Average Tenure
56yo
Average Age

Experienced Board: 1466's board of directors are considered experienced (3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/16 05:57
End of Day Share Price 2025/11/14 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Baijin Life Science Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.